PatientsCann UK · Education
Understanding Cannabinoids
Cannabinoids are the active compounds in cannabis. They are the reason a cannabis medicine can ease pain, calm the mind, or help with sleep. This guide explains what they are, how they work in your body, and why heating the plant changes everything.
What are cannabinoids?
Cannabinoids are a family of natural compounds made by the cannabis plant. Scientists have found more than 100 of them. They are the part of the plant that makes it useful as a medicine.
Each cannabinoid has its own job. THC eases pain and sickness but also causes the "high". CBD is calming and does not make you high. Others, like CBG and CBN, are being studied for focus, sleep and much more.
Your body already makes its own cannabinoid-like chemicals. Plant cannabinoids work by borrowing the same network in your body. Scientists call it the endocannabinoid system, or ECS for short.
Cannabinoids rarely work alone
Alongside the aroma compounds called terpenes, cannabinoids seem to work better together than apart. Scientists call this the "entourage effect". It is one reason a whole-plant medicine can feel different from a single pure cannabinoid. Learn more on our terpenes guide.
Interactive
How Cannabinoids Work in the Body
Your endocannabinoid system has two main "locks", called receptors: CB1 and CB2. Cannabinoids are the "keys". CB1 sits mostly in the brain and nerves. CB2 sits mostly in the immune system and around the body. Pick a cannabinoid below to see which locks it fits, and what that might mean for you.
Interactive
Raw vs Heated: Why Cannabis Must Be Warmed
Here is something that surprises most people: raw cannabis will not get you high. The plant does not make THC or CBD directly. It makes their acid forms first, called THCA and CBDA. Only when you add heat, by vaping, smoking or cooking, do these acids lose a tiny piece (a carbon dioxide molecule) and turn into THC and CBD. This is called decarboxylation. Follow the pathway, tap any molecule to see its structure, then press Apply heat.
Interactive
In Your Body: What Happens to THC
Heating the plant makes THC, but the story does not end there. Once THC is inside you, your liver changes it step by step into new molecules. One of them is stronger than THC itself. This is the hidden reason an eaten edible can feel so different from a vape, and why the same dose can affect two people in completely different ways.
11-Hydroxy-THC is a metabolite: a new molecule your body makes while breaking THC down. It is not in the plant. It fits the CB1 receptor even better than THC, so it is stronger and reaches the brain more easily.
Does the route change things? Try it
Fast and lighter. Inhaled THC goes almost straight to your brain, mostly unchanged. Very little becomes 11-hydroxy-THC. Onset is quick (minutes) and the effect fades sooner.
The breakdown pathway
Why edibles feel stronger
When you eat cannabis, most of the THC is turned into 11-hydroxy-THC before it reaches your bloodstream. A gentle vape and an intense edible can come from the very same flower. (Huestis, 2007)
Why they fail for some
Everyone's liver runs at a different speed. The main enzyme, CYP2C9, comes in different genetic versions, so blood levels from the same dose vary widely between people. (Sachse-Seeboth et al., 2009)
A fast liver can rush THC through to the inactive THC-COOH and clear it before much is felt, so a normal edible seems to do nothing.
Where nano-emulsions help
Nano-emulsified edibles wrap THC in tiny food-safe droplets, so more is absorbed, faster, and some slips past the liver's first pass. They do not make THC more powerful; they make the dose more reliable. (Hermush et al., 2025)
At a glance
THC vs CBD: The Two You Hear About Most
THC and CBD come from the same plant and look almost identical under a microscope, yet they behave very differently in the body. Here is the simple version.
THC
Delta-9-tetrahydrocannabinol
- Makes you high?
- Yes. It switches on CB1 in the brain.
- Mainly used for
- Pain, muscle spasm, nausea, appetite and sleep.
- How it works
- Directly activates the CB1 and CB2 receptors.
- UK status
- Prescription only, from a specialist doctor.
- Watch for
- Anxiety, a racing heart or dizziness at higher doses.
CBD
Cannabidiol
- Makes you high?
- No. It barely touches CB1.
- Mainly used for
- Anxiety, epilepsy, inflammation and calm.
- How it works
- Acts mostly on other targets, and softens THC.
- UK status
- Low-THC CBD sold as a supplement; medical CBD is prescribed.
- Watch for
- Usually well tolerated; can interact with some medicines.
Full library
The Cannabinoid Family
Select any card to open the full profile, with its accurate chemical structure, how it works, what the research says, and safety notes. Use the filters to narrow the list.
Questions
Cannabinoids: Your Questions Answered
What is the difference between THC and CBD?
Which cannabinoid gets you high?
Do I need a prescription for cannabinoids in the UK?
What is the endocannabinoid system?
Why does cannabis need to be heated?
Are cannabinoids addictive?
What is the entourage effect?
Why don't edibles work for some people?
What is 11-hydroxy-THC?
References
- Baram, L. et al. (2022) 'Major cannabis terpenes, applied individually and in combination, activate endogenous cannabinoid CB1 and CB2 receptors', Frontiers in Pharmacology, 13, 1040962. doi: 10.3389/fphar.2022.1040962.
- ElSohly, M.A. and Gul, W. (2014) 'Constituents of Cannabis sativa', in Pertwee, R. (ed.) Handbook of Cannabis. Oxford: Oxford University Press, pp. 3-22.
- Gaoni, Y. and Mechoulam, R. (1964) 'Isolation, structure, and partial synthesis of an active constituent of hashish', Journal of the American Chemical Society, 86(8), pp. 1646-1647. doi: 10.1021/ja01062a046.
- Grotenhermen, F. (2003) 'Pharmacokinetics and pharmacodynamics of cannabinoids', Clinical Pharmacokinetics, 42(4), pp. 327-360. doi: 10.2165/00003088-200342040-00003.
- Hermush, V. et al. (2025) 'Enhancing cannabinoid bioavailability: a crossover study comparing a novel self-nanoemulsifying drug delivery system and a commercial oil-based formulation', Journal of Cannabis Research, 7, 31. doi: 10.1186/s42238-025-00294-8.
- Huestis, M.A. (2007) 'Human cannabinoid pharmacokinetics', Chemistry & Biodiversity, 4(8), pp. 1770-1804. doi: 10.1002/cbdv.200790152.
- Izzo, A.A. et al. (2009) 'Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb', Trends in Pharmacological Sciences, 30(10), pp. 515-527. doi: 10.1016/j.tips.2009.07.006.
- Morales, P., Hurst, D.P. and Reggio, P.H. (2017) 'Molecular targets of the phytocannabinoids: a complex picture', Progress in the Chemistry of Organic Natural Products, 103, pp. 103-131. doi: 10.1007/978-3-319-45541-9_4.
- National Center for Biotechnology Information (2025) PubChem Compound Database. Bethesda: U.S. National Library of Medicine. Available at: https://pubchem.ncbi.nlm.nih.gov (Accessed: 29 July 2026).
- Pertwee, R.G. (2008) 'The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta-9-tetrahydrocannabinol, cannabidiol and delta-9-tetrahydrocannabivarin', British Journal of Pharmacology, 153(2), pp. 199-215. doi: 10.1038/sj.bjp.0707442.
- Russo, E.B. (2011) 'Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects', British Journal of Pharmacology, 163(7), pp. 1344-1364. doi: 10.1111/j.1476-5381.2011.01238.x.
- Sachse-Seeboth, C. et al. (2009) 'Interindividual variation in the pharmacokinetics of delta-9-tetrahydrocannabinol as related to genetic polymorphisms in CYP2C9', Clinical Pharmacology & Therapeutics, 85(3), pp. 273-276. doi: 10.1038/clpt.2008.213.
- UK Government (2018) The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. London: The Stationery Office.
- Watanabe, K. et al. (2007) 'Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes', Life Sciences, 80(15), pp. 1415-1419. doi: 10.1016/j.lfs.2006.12.032.